These systems employ sophisticated silica-column technology to simultaneously isolate fragmented cfDNA and cfRNA, encompassing both protein-bound and exosomal fractions. They promote smooth multi-omics integration and high-resolution NGS library preparation by preserving genomic integrity and removing enzymatic inhibitors without the use of harmful phenol-chloroform methods.
What you will discover:
Quick-cfDNA/cfRNA™ Serum & Plasma Kit: An efficient spin-column setup tailored for sample volumes up to 3 ml, providing reduced sequence bias and recovering as much as 515 times more microRNA.
High-Purity Elution Technology: Nuclease-free methods enabling the separate or co-elution of nucleic acids, ensuring transfection-grade purity for delicate bioinformatics and RT-qPCR uses.
MBP Inc. offers reproducibility-validated tools that guarantee linear recovery and reliable biomarker isolation for enhanced clinical monitoring.
Close the gap between liquid biopsy and groundbreaking discovery—reach out to MBP Inc. now to obtain a quote for your next-generation sequencing requirements.